Zobrazeno 1 - 10
of 35
pro vyhledávání: '"van Horssen-Zoetbrood A"'
Autor:
de Rijke, Björn a, van Horssen-Zoetbrood, Agnes a, Veenbergen, Sharon a, Fredrix, Hanny a, de Witte, Theo b, van de Wiel-van Kemenade, Elly a, Dolstra, Harry a, ⁎
Publikováno v:
In Journal of Immunological Methods 1 January 2008 329(1-2):125-137
Autor:
Theo de Witte, Elly van de Wiel-van Kemenade, Harry Dolstra, Björn de Rijke, Agnes van Horssen-Zoetbrood, Hanny Fredrix, Sharon Veenbergen
Publikováno v:
Journal of Immunological Methods, 329, 125-37
Journal of Immunological Methods, 329, 1-2, pp. 125-37
Journal of Immunological Methods, 329, 1-2, pp. 125-37
Contains fulltext : 71202.pdf (Publisher’s version ) (Closed access) Minor histocompatibility antigens (mHAgs) constitute the target antigens of the T cell-mediated graft-versus-leukemia response after HLA-identical allogeneic stem cell transplanta
Autor:
Mark Leppert, Britt Otterud, Frans Maas, Anton Schattenberg, Björn de Rijke, Elly van de Wiel-van Kemenade, Theo de Witte, Agnes van Horssen-Zoetbrood, Rob Woestenenk, Jeffrey M. Beekman, Michel G.D. Kester, Harry Dolstra
Publikováno v:
Journal of Clinical Investigation, 115, 3506-16
Journal of Clinical Investigation, 115, 12, pp. 3506-16
Journal of Clinical Investigation, 115, 12, pp. 3506-16
Contains fulltext : 48913.pdf (Publisher’s version ) (Open Access) Minor histocompatibility antigens (mHAgs) constitute the targets of the graft-versus-leukemia response after HLA-identical allogeneic stem cell transplantation. Here, we have used g
Autor:
T Henriëtte Levenga, Harry Dolstra, Ingrid M. Overes, Robbert van der Voort, Johanna C. M. Vos, Pieter H.M. De Mulder, Theo de Witte, Agnes van Horssen-Zoetbrood
Publikováno v:
Cancer Immunology Immunotherapy, 58, 429-39
Cancer Immunology Immunotherapy, 58, 3, pp. 429-39
Cancer Immunology Immunotherapy, 58, 3, pp. 429-39
Contains fulltext : 79614.pdf (Publisher’s version ) (Closed access) CD8(+) T cells recognizing minor histocompatibility antigens (MiHA) on solid tumor cells may mediate effective graft-versus-tumor (GVT) reactivity after allogeneic stem cell trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71328087177f269f89fa781f47b83d4b
http://hdl.handle.net/2066/79614
http://hdl.handle.net/2066/79614
Autor:
Harry Dolstra, J Han J M van Krieken, Joop H. Jansen, Ingrid M. Overes, Björn de Rijke, Theo de Witte, Robbert van der Voort, Reinier Raymakers, Agnes van Horssen-Zoetbrood, Hanny Fredrix, Aniek O. de Graaf
Publikováno v:
British Journal of Haematology, 141, 799-807
British Journal of Haematology, 141, 6, pp. 799-807
British Journal of Haematology, 141, 6, pp. 799-807
Contains fulltext : 70311.pdf (Publisher’s version ) (Closed access) Minor histocompatibility antigens (MiHA) selectively expressed by haematopoietic cells are attractive targets for specific immunotherapy after allogeneic stem cell transplantation
Autor:
Harry Dolstra, Johanna C. M. Vos, T. de Witte, Henriette Levenga, Ingrid M. Overes, Pieter H.M. De Mulder, Agnes van Horssen-Zoetbrood, Robbert van der Voort
Publikováno v:
Blood. 110:1795-1795
Allogeneic stem cell transplantation (SCT) in combination with donor lymphocyte infusion (DLI) is an experimental treatment for patients with metastatic solid tumors. The therapeutic efficacy is attributed to the graft-versus-tumor (GVT) response dur
Autor:
Han van Krieken, Reinier Raymakers, Hanny Fredrix, Robbert van der Voort, Ingrid M. Overes, Agnes van Horssen-Zoetbrood, Harry Dolstra, T. de Witte, Björn de Rijke
Publikováno v:
Blood. 108:138-138
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potent treatment for patients with hematological malignancies. The therapeutic efficacy is attributed to the graft-versus-tumor (GVT) response during which donor-derived cytotoxic T lymph
Autor:
Annemieke Vos, Anton Schattenberg, Ingrid M. Overes, Robbert van der Voort, Harry Dolstra, Inge Jedema, T. de Witte, Wieger J. Norde, J.H. Frederik Falkenburg, Agnes van Horssen-Zoetbrood
Publikováno v:
Blood. 108:134-134
Allogeneic stem cell transplantation (SCT) is a specialized form of immunotherapy for treating patients with hematological malignancies. The curative potential is attributed to the graft-versus-tumor (GVT) response during which donor-derived cytotoxi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.